Investigation on marking method for phenomenon on regrowth drug resistance in relapsed acute myelogenous leukemia

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 21, Issue 4, 2001, Pages 286-288

  Chen, Yan ^a   He, Mingsheng ^a   Wu, Yudan ^a   Li, Huiyu ^a   Yu, Dongjiao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute; Leukemia; MyelogenousX; Regrowth drug resistance; Scoring criteria

Indexed keywords

ACUTE; LEUKEMIA; MYELOGENOUSX; REGROWTH DRUG RESISTANCE; SCORING CRITERIA;

CELLS; ENZYMES; PATIENT TREATMENT; TUMORS;

DRUG THERAPY;

ANTINEOPLASTIC AGENT; GLYCOPROTEIN; P 170 GLYCOPROTEIN, HUMAN; P-170 GLYCOPROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; DRUG RESISTANCE; DRUG SCREENING; FEMALE; GENETICS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GLYCOPROTEINS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RECURRENCE;

EID: 24744462945     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02886558     Document Type: Article

References (10)

1. Preisler H D, Venugopal P. Regrowth resistance in cancer: why has it been largely ignored. Cell Prolif, 1995, 28):347
2. Preisler H Di Gropal V. Regrowth drug resistance in leukemia and lymphoma: the need for a new system to classify treatmetn failure and for approaches to treatment. Leuk Res, 1994, 18, 149
3. Raza A, Yasin Z, Gande C. A comparison of rate of DNA synthesis in myeloblasts from peripheral blood and bone marrows of patients with acute nonlymphocytic leukemia. Exp Cell Res, 1988, 176, 13
4. Boise L H, Gonzalez-Garcia M, Postema CE et al. Bcl-X, a bcl-2- related gene that functions as a dominant regulator of apoptotic cell death. Cell, 1993, 74, 597
5. Estey E H. Regrowth resistance. Leuk Res, 1994, 18, 161
6. Smyth M J, Krasovskis E, Sutton V R et al. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspasc-de-pendent apoptosis. Proc Natl Acad Sci USA, 1998, 95: 7024